19, May 2022
The advancement in medical devices and technology has eradicated the deficiency of artificial supplements. Medical collagen is a type of artificial protein extracted from the bones and skins of various animals such as pigs, cows, etc. It is a protein-enriched supplement used across various industries.
Our study indicates that the global medical collagen market will advance at a CAGR of 6.57% during the forecasted period, 2022-2028. The healthcare sector drives the market’s growth with its increasing consumption for treatment purposes such as wounds, surgery, burns, etc. Also, the outcome of COVID-19 presented a profitable market owing to the increased focus on the quality of life and food among people. This further escalated the growing consumption of collagen-enriched products and their demand as a supplement.
The association of medical collagen with animal-based ingredients restricts vegans and pious groups from accepting the supplement. Besides, over-consumption of collagen causes side effects like digestion-related problems such as bloating, heartburn, etc. Adding to this, people avoid consuming these collagen supplements.
The application segment of the market is divided into wound care, bone grafts, tissue scaffolds, cartilage repair, hemostats, diagnostics, vascular grafts, and other applications.
The use of collagen in wound care is attributed to increasing road accidents and the growing prevalence of chronic diseases. Collagen-based technology stimulates the growth of new tissue due to the presence of abundant protein in it.
Moreover, the implementation of collagen in food products has given a pump to the market in the food industry. Consumers are abundantly using these supplements in their diet to strengthen their bones and overall health. This has augmented the consumption of different collagen supplements.
Additionally, the market is likely to grow significantly in the upcoming years because of the rising skin and hair-related problems, creating potential prospects for the market.
The medical collagen market is segmented into the source, product type, and application. Following are the factors within the segments that drive the growth of the market:
Bovine, Porcine, and other sources are covered under the source segment of the market. Bovine influences the source segment as major players in the market, namely, Gelita, Tessenderlo Group, Weishardt, Collagen Matrix Inc, Lapi Gelatine, Symatese, Stryker, Jellagen, Darling Ingredients Inc, Italgel, etc., prefer bovine over the other sources in the production of collagen-based products. Also, it helps boost collagen types I and III useful for human beings to fulfill their body requirements. Therefore, the benefits of the bovine source are boosting the demand for collagen.
The product segment is categorized into gelatine, hydrolyzed collagen, native collagen, and others.
Gelatine holds the dominating position in terms of share in the segment. It is because many companies produce products using gelatine. Moreover, gelatine has a high amount of protein as it is produced from protein-enriched sources like bovine and porcine. There are multiple benefits offered by gelatine-based products that raise their demand in the studied market.
Our study on the global medical collagen market includes the evaluation of regions: North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America.
North America holds the leading position at a CAGR of 6.12% and is expected to rise in the forthcoming years. Owing to the growing consumption of collagen supplements, emerging needs in healthcare sectors, and the rising usage of medical devices, the key players in the region have strengthened their manufacturing and production of medical collagen.
Furthermore, Asia-Pacific is likely to rise at a CAGR of 7.23% in the forecasting years. The growth is attributed to the flourishing skincare and beauty products, wide acceptance of meat-based products among consumers, and the inclusion of collagen as an ingredient in the food and beverage industry.
The upsurge in the applications as supplements reflects the medical collagen market’s future growth. Technological advancement and significant investment in R&D activities have allowed market players to launch new products. Moreover, consciousness among consumers regarding their health has showcased the importance of collagen-based products across industries like cosmetics, healthcare, food & beverage, etc. Furthermore, significant investment in biotechnology R&D is likely to excel the demand for medical collagen in the upcoming years. For instance, Nitta Gelatin India Ltd. launched gelatine at the international level manufactured using Japanese technology.
Question: What is the key application expected to raise the market’s growth?
Answer: Tissue scaffolds is the key application expected to boost the market’s growth. It accelerates cellular growth and proliferation during the implantation process in patients.
Prevalent cases of terrorist attacks in today’s world is increasing the need for severe standards of security for public safety, and the global market for biometric technology scrupulously accommoda..
Prevalent cases of terrorist attacks in today’s world is increasing the need for..
